Ashurst advises on £703.1 million recommended takeover of Ergomed by Permira Advisers

Insight Hero Image

    Global law firm Ashurst is advising Rothschild & Co on the approximately £703.1 million recommended cash offer for AIM listed company Ergomed plc (Ergomed) by Eden AcquisitionCo Limited, a newly incorporated entity formed by funds advised by Permira Advisers LLP (Permira).

    Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval PV and medical information. Ergomed's fast-growing services business includes an industry-leading suite of specialist PV solutions, integrated under the PrimeVigilance brand, a full range of high-quality clinical research and trial management services under the Ergomed brand and mission-critical regualtory compliance and consulting services under the ADAMAS brand.

    The Ashurst team was led by partners Tom Mercer, Harry Thimont and Tim Rennie, assisted by senior associates Maria McAlister and Aimee Carroll-Hewitt and associates Sandile Sibiya, Millie Gibbs, Gareth Mair and Roshni Mehra.